The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation

SIMPLE SUMMARY: Oncological follow-up after liver transplantation for cholangiocellular carcinoma must consider the risk of recurrence. Immunosuppressive medication with so-called mTOR inhibitors seems to have a tumor-suppressive effect, as improved survival has been shown under this medication for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gül-Klein, Safak, Schmitz, Paulina, Schöning, Wenzel, Öllinger, Robert, Lurje, Georg, Jonas, Sven, Uluk, Deniz, Pelzer, Uwe, Tacke, Frank, Schmelzle, Moritz, Pratschke, Johann, Ossami Saidy, Ramin Raul, Eurich, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221145/
https://www.ncbi.nlm.nih.gov/pubmed/35740555
http://dx.doi.org/10.3390/cancers14122890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221145/
https://www.ncbi.nlm.nih.gov/pubmed/35740555
http://dx.doi.org/10.3390/cancers14122890

Ejemplares similares